Embedding guideline directed care and international consensus on desensitization strategies
As science advances and innovative new approaches to desensitization in kidney transplantation become available, new clinical guidelines are needed. Over the last four years, the clinical community and influential professional societies have recognized and taken up the charge to establish more consistent approaches to desensitization thus enabling kidney transplantation for highly sensitized patients.
In fact, since 2020 Hansa has collaborated with the European Society for Organ Transplantation (ESOT) and convened key transplant community thought leaders to identify and align on the challenges of desensitization, patient prioritization schemes, and agree on opportunities to increase access to transplantation for highly sensitized kidney transplant candidates, including the appropriate use of innovative new desensitization strategies.
In 2022, ESOT published the first set of clinical guidelines representing the first international consensus on a management pathway for highly sensitized patients.18 The guidelines serve as a foundation for country-specific guidelines and consensus across Europe.
Healthcare policy as a catalyst to improve equity and patient outcomes
Equitable access to transplantation needs to be embedded within healthcare policy frameworks in each country to ensure success.
In the European Union, work is underway to create a new EU Action Plan on Organ Donation and Transplantation. This Action Plan may give the EU an opportunity to harmonize approaches to transplantation among countries, improve coordination, and increase the number of transplant recipients.
The work is being championed by the European Kidney Health Alliance (EKHA) whose recent Kidney Manifesto for the EU calls for: improvements to the primary and secondary prevention of kidney disease; improved organ donation and transplantation; and for the EU to support innovation in kidney therapies.19 Critically the call to action on transplantation is the development and implementation of a new EU Action Plan on Organ Donation and Transplantation. We believe the implementation of the action plan, embedded in EU and ultimately Member State healthcare policy, would ensure more equitable access for currently underserved patients, including highly sensitized kidney transplant patients.
“The recently elected EU Parliament must ensure that kidney health is a key priority. Chronic kidney disease is the fastest rising cause of death, and if we don’t act now chronic kidney disease will be the 5th leading cause of death by 2050.”, said Professor Raymond Vanholder, EKHA President. “To mitigate this burden, one of the options is creating a new EU Action Plan on Organ Donation and Transplantation to drive forward change in transplantation. We look forward to working with the Hungarian EU Presidency during second semester of 2024 to move this forward and ensure the new Action Plan is created and implemented.”